Vanda Pharmaceuticals (VNDA) PT Raised to $24 at Brean Capital Following Fanapt Ruling
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Vanda Pharmaceuticals (VNDA) Announces USPTO Dismissal of '432 Patent Inter Partes Review
August 30, 2016 3:01 PM EDTVanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that the United States Patent and Trademark Office (USPTO) Patent Trials and Appeal Board declined the request by Roxane Laboratories, Inc. (Roxane) to institute an inter partes review of U.S. Patent No. 9,138,432 ("the '432 patent").... More
Vanda Pharmaceuticals (VNDA) Affirms Receipt of Favorable Court Decision in Fanapt Patent Suit
August 25, 2016 2:52 PM EDTVanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced that Judge Gregory M. Sleet of the United States District Court for the District of Delaware ruled that Roxane Laboratories Inc. (Roxane) infringed U.S. Patent Nos. RE39,198 (the '198 Patent) and 8,586,610 (the '610 Patent) by... More
UPDATE: Vanda Pharmaceuticals (VNDA) Surges 10% Mid-Day
August 25, 2016 11:37 AM EDT(Updated - August 25, 2016 11:43 AM EDT)
Vanda Pharmaceuticals (NASDAQ: VNDA) spikes higher. Shares up 10%.
UPDATE: Vanda Pharmaceuticals wins ruling over patent for Fanapt, per Bloomberg.
... More
